Surgical management of thymic epithelial tumors

Resection is the mainstay of treatment for thymic epithelial tumors (TETs), with complete removal of the tumor and involved organs being the ultimate aim. The choice of surgical approach plays a major role in defining treatment success, and the optimal choice of method should thus provide an adequate surgical view to achieve complete tumor resection. While median sternotomy is considered the gold standard for access to the mediastinum, several minimally invasive approaches to thymectomy have been described, including video-assisted robotic-assisted thymectomy, although the oncological outcomes of that procedure remain unclear. A multimodal approach incorporating chemotherapy or chemoradiotherapy followed by extended surgery may improve resectability and outcomes for patients with advanced TETs. Surgical debulking is also reportedly acceptable for invasive thymoma because of its potential for achieving favorable outcomes. Re-resection is an acceptable option for patients with recurrent thymoma after initial resection, and repeat resection for recurrent pleural dissemination seems effective. Here, the literature on current clinical practices in the surgical management and treatment of TETs is reviewed.

Automated summary

Surgical resection is the main treatment for thymic epithelial tumors, aiming for complete removal of the tumor and involved organs. The choice of surgical approach is crucial for treatment success, with minimally invasive methods like video-assisted robotic-assisted thymectomy also being explored. A multimodal approach incorporating chemotherapy or chemoradiotherapy followed by extended surgery may improve outcomes for patients with advanced TETs.